XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.2
FAIR VALUE MEASUREMENT (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024:

 

   June 30, 2025 
   Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $1,955   $1,955 
                     
   $   $   $1,955   $1,955 

 

 

   December 31, 2024 
   Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $4,554,640   $4,554,640 
                     
   $   $   $4,554,640   $4,554,640 
SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS

The following table represents the change in Level 3 tier value measurements for the six months ended June 30, 2025:

 

  

Warrant

Derivative
Liabilities

 
     
Balance, December 31, 2024  $4,554,640 
      
Issuance of pre-funded warrant derivative liabilities in February 2025 public equity offering   1,803 
      
Issuance/Activation of Series A Warrants issued in connection with the February 2025 public equity offering   1,340,214 
      
Issuance/Activation of Series B Warrants issued in connection with the February 2025 public equity offering   5,406,408 
      
Transition of warrant derivative liability to equity due to exercise of pre-funded warrant derivative liabilities in February 2025 public equity offering   (1,803)
      
Transition of warrant derivative liability to equity due to exercise of Series B common stock purchase warrants issued in June 2024 Private Placement   (1,989,806)
      
Transition of warrant derivative liability to equity due to exercise of Series B common stock purchase warrants issued in February 2025 Public Equity Offering   (5,406,320)
      
Transition of warrant derivative liability to equity due to elimination of net cash settlement provisions relative to the Series A common stock purchase warrants issued in February 2025 Public Equity Offering   (530,101)
      
Change in fair value of warrant derivative liabilities   (3,373,080)
      
Balance, June 30, 2025  $1,955